B Lynne Parshall

B Lynne Parshall has an estimated net worth of $56.4 Million. This is based on reported shares across multiple companies, which include CYTOKINETICS INC, AKCEA THERAPEUTICS, INC., Regulus Therapeutics Inc., IONIS PHARMACEUTICALS INC, Foghorn Therapeutics Inc., CORAUTUS GENETICS INC, and CARDIODYNAMICS INTERNATIONAL CORP.

2013 was B Lynne Parshall's most active year for acquiring shares with 27 total transactions. B Lynne Parshall's most active month to acquire stocks was the month of December. 2014 was B Lynne Parshall's most active year for disposing of shares, totalling 82 transactions. B Lynne Parshall's most active month to dispose stocks was the month of November. 2012 saw B Lynne Parshall paying a total of $3,430,906.50 for 7,212,615 shares, this is the most they've acquired in one year. In 2014 B Lynne Parshall cashed out on 1,777,450 shares for a total of $28,412,786.53, their largest year based on trade value.